Sabra Reports Second Quarter 2019 Results; Significantly Improves Leverage and Other Credit Metrics; Reaffirms 2019 Guidance

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/23/2026

1. META
2. TSLA
3. IBM
4. TXN
5. MRNA
6. SAP
7. CSX
8. LRCX
9. MRK
10. LVS

Go back to Sabra Reports Second Quarter 2019 Results; Significantly Improves Leverage and Other Credit Metrics; Reaffirms 2019 Guidance

Sabra Health Care REIT (SBRA) Tops Q2 EPS by 9c, Revenues Beat

August 7, 2019 4:34 PM EDT

Sabra Health Care REIT (NASDAQ: SBRA) reported Q2 EPS of $0.46, $0.09 better than the analyst estimate of $0.37. Revenue for the quarter came in at $219.37 million versus the consensus estimate of $164.69 million.

Commenting on the second quarter results, Rick Matros, CEO and Chairman, said, This quarter saw the successful execution of Sabras first investment grade issuance, continuing to demonstrate the ongoing benefits and results of our completed repositioning. Additionally, we made significant progress on de-levering our balance sheet, have full commitments for our proposed amended credit facility and... More